Pemetrexed and carboplatin in the treatment of malignant pleural mesothelioma (MPM)

被引:0
|
作者
Papi, M.
Genestreti, G.
Tassinari, D.
Tamburini, E.
Nicoletti, S.
Nicolini, M.
Fabbri, P.
Fabbri, P.
Santo, A.
Pasquini, E.
Ravaioli, A.
机构
[1] City Hosp, Rimini, Italy
[2] City Hosp, Forli, Italy
[3] City Hosp, Cattolica, Italy
[4] City Hosp, Verona, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
18114
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Immunotherapy, the promise for present and future of malignant pleural mesothelioma (MPM) treatment
    Gounant, Valerie
    Brosseau, Solenn
    Zalcman, Gerard
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [42] Carboplatin Plus Pemetrexed as First-line Treatment of Patients With Malignant Pleural Mesothelioma: A Phase II Study
    Katirtzoglou, Nikolaos
    Gkiozos, Ioannis
    Makrilia, Nektaria
    Tsaroucha, Emilia
    Rapti, Aggeliki
    Stratakos, Grigorios
    Fountzilas, Georgios
    Syrigos, Konstantinos N.
    [J]. CLINICAL LUNG CANCER, 2010, 11 (01) : 30 - 35
  • [43] Real World use of Cisplatin and Carboplatin Based Therapy in Patients with Malignant Pleural Mesothelioma (MPM)
    Cedres, S.
    Assaf, J. D.
    Iranzo, P.
    Callejo, A.
    Pardo, N.
    Navarro, A.
    Martinez-Marti, A.
    Valdivia, A.
    Filipi-Arriaga, F.
    Monton, V.
    Gonzalo, J.
    Pedrola, A.
    Recasens, S.
    Madrenas, R.
    Feliu, B.
    Roman, B.
    Dienstmann, R.
    Felip, E.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S379 - S380
  • [44] Weekly Epirubicin as palliative treatment in patients with malignant pleural mesothelioma (MPM)
    Belloni, P.
    Cozzi, C.
    Zannier, F.
    Della Torre, S.
    Toniolo, D.
    Corradini, G. M.
    Candido, P.
    Bollina, R.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [45] Pemetrexed second-line treatment in malignant pleural mesothelioma (MPM) following platinum-based first-line treatment
    Sorensen, Jens B.
    Sundstrom, Stein
    Perell, Katharina
    Thielsen, Anne-Kathrine
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 216 - 216
  • [46] Retreatment with pemetrexed-based chemotherapy (PBC) in patients with malignant pleural mesothelioma (MPM): An observational study
    De Vincenzo, F.
    Zucali, P.
    Ceresoli, G.
    Gianoncelli, L.
    Lorenzi, E.
    Simonelli, M.
    Ripa, C.
    Giordano, L.
    Santoro, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [47] Treatment with gemcitabine and vinorelbine (GEMVIN) as second-line chemotherapy in pemetrexed-pretreated patients with malignant pleural mesothelioma (MPM)
    Garassino, Isabella
    Ceresoli, Giovanni L.
    De Vincenzo, Fabio
    Zucali, Paolo A.
    Cavina, Raffaele
    Campagnoli, Elisabetta
    Salamina, Silvia
    Parra, Hector J. Soto
    Santoro, Armando
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 231 - 231
  • [48] The Role of Pemetrexed in the Pharmacotherapy of Malignant Pleural Mesothelioma
    Zucali, P. A.
    De Vincenzo, F.
    Simonelli, M.
    Lorenzi, E.
    Perrino, M.
    Santoro, A.
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2010, 2 : 797 - 808
  • [49] Malignant pleural mesothelioma: maintenance chemotherapy with pemetrexed
    Nacci, A.
    Rizzo, P.
    Sponziello, F.
    Mazzoni, E.
    Fedele, P.
    Orlando, L.
    Schiavone, P.
    Calvani, N.
    Marino, A.
    Cinieri, S.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S833 - S833
  • [50] Pemetrexed in malignant pleural mesothelioma and the clinical outcome
    Knuuttila, Aija
    Salomaa, Eija-Riitta
    Saikkonen, Suvi
    Hurme, Saija
    Salo, Jarmo
    [J]. CLINICAL RESPIRATORY JOURNAL, 2012, 6 (02): : 96 - 103